Zobrazeno 1 - 10
of 59
pro vyhledávání: '"S, Letasiova"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Markus, Y. Kaluzhny, G.R. Jackson, O. Gabriel, S. Letasiova, M. Klausner, P. Kearney, A. Armento, L. Hudecova
Publikováno v:
Toxicology Letters. 368:S208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d2bbf9b0ca54724855025c016153bd0
https://doi.org/10.1016/j.toxlet.2022.07.563
https://doi.org/10.1016/j.toxlet.2022.07.563
Publikováno v:
Toxicology Letters. 368:S191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::953aa841bd17dc0cd92b2586e336681b
https://doi.org/10.1016/j.toxlet.2022.07.522
https://doi.org/10.1016/j.toxlet.2022.07.522
Publikováno v:
Toxicology Letters. 350:S232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf52ba676a165977a7c0c1c9c8339031
https://doi.org/10.1016/s0378-4274(21)00780-3
https://doi.org/10.1016/s0378-4274(21)00780-3
Autor:
Els Adriaens, Annette Mehling, E. van Vliet, Boris P. Müller, David A. Basketter, Bruno Hubesch, S. Letasiova, Erwin Ludo Roggen, A. Irizar, Silvia Casati, Martina Klaric, Irene Manou
Publikováno v:
Regulatory Toxicology and Pharmacology. 108:104473
In the last 20 years, alternative approaches to the identification of skin sensitisation hazards have been at the forefront of the 3Rs and have helped refine the validation and acceptance processes. However, experience with the local lymph node assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d589309d4edf69ad1c2a6caf0ffad603
https://doi.org/10.1016/j.yrtph.2019.104473
https://doi.org/10.1016/j.yrtph.2019.104473
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
H. Kandarova, J. Willoughby, W. de Jong, M. Bachelor, S. Letasiova, B. Breyfogle, L. de la Fonteyne, K. Coleman
Publikováno v:
Toxicology Letters. 238:S351-S352
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31a7716bda059a6f496254379b5ce7ed
https://doi.org/10.1016/j.toxlet.2015.08.1004
https://doi.org/10.1016/j.toxlet.2015.08.1004
Publikováno v:
Experimental oncology. 30(2)
Quinazolines are known to be multitarget agents with broad spectrum of biological activity.To investigate anticancer activity of newly prepared 6-bromo-2-(morpholin-1-yl)-4-anilinoquinazoline (BMAQ) towards L1210, HL-60 and U-937 leukemia cells.Growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::efcf7417e4a7ef31304c56d101a4cbab
https://pubmed.ncbi.nlm.nih.gov/18566578
https://pubmed.ncbi.nlm.nih.gov/18566578
Publikováno v:
Neoplasma. 55(4)
The purpose of this study was to evaluate the cytotoxicity of two formulations of hydroxyapatite (HA), namely fluorapatite (FA) and fluor-hydroxyapatite (FHA). HA is used as carrier material for antibiotics or anticancer drugs during treatment of bon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::295951a911cca72f14f8a795c6d0efa4
https://pubmed.ncbi.nlm.nih.gov/18505342
https://pubmed.ncbi.nlm.nih.gov/18505342
Publikováno v:
Neoplasma. 54(1)
The purpose of this study was to investigate the therapeutic potential of a newly synthesized [1,2,4]triazolo[4,3-c]quinazoline (NTCHMTQ) alone and in combination with two anticancer drugs (cisplatin and temozolomide) against HL-60 leukemia cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::872cf2216fab2048ed37a51c739538b7
https://pubmed.ncbi.nlm.nih.gov/17203888
https://pubmed.ncbi.nlm.nih.gov/17203888